Physician profile

Traci R Evans

Adult Health (Nurse Practitioner) · Gulfport, MS

NPI 1982978771

$8,179.32

in general payments reported to CMS, 2019-2025

41 companies · $1,165 in 2025

The $1,165 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

See the full distribution for Adult Health (Nurse Practitioner)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,266.38

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $1,087.88 2021-2025 Mounjaro, Jardiance, Zepbound
Dexcom, INC. $934.40 2021-2025 Dexcom G6 Transmitter
Abbott Laboratories $871.97 2021-2025 Freestyle Libre
Bayer Healthcare Pharmaceuticals INC. $585.41 2021-2025
Medtronic, INC. $572.44 2021-2025 Minimed 780g
Amgen INC. $516.87 2021-2025 Evenity, Prolia, Repatha
Xeris Pharmaceuticals, INC. $496.55 2021-2024 Gvoke Hypopen, Recorlev
Novo Nordisk INC $433.26 2021-2025 Ozempic, Rybelsus, Wegovy
Corcept Therapeutics $431.96 2021-2025 Korlym
Sanofi-Aventis U.S. LLC $303.38 2021-2024
Grt US Holding, INC. $242.67 2021-2022
Averitas Pharma INC. $226.25 2023-2025 Qutenza
Boehringer Ingelheim Pharmaceuticals, INC. $210.28 2021-2025 Jardiance
Astrazeneca Pharmaceuticals LP $184.98 2021-2023 Farxiga
Merck Sharp & Dohme LLC $123.88 2021
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Radius Health, INC. $103.03 2021-2023
Becton, Dickinson and Company $84.30 2022
Insulet Corporation $71.65 2022-2025 Omnipod
Novartis Pharmaceuticals Corporation $69.71 2023-2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $64.03 2021
Abbvie INC. $57.17 2022-2024
Recordati_rare_diseases_inc. $52.71 2021-2024 Isturisa, Signifor Lar
Vistapharm, INC. $47.13 2021
Takeda Pharmaceuticals U.S.A., INC. $46.48 2021-2022
Acerus Pharmaceuticals Corporation $35.89 2022
Vifor Pharma, INC. $35.40 2021
Rochester Medical Corporation $32.74 2021
Smith+Nephew, INC. $30.21 2022
Amarin Pharma, INC. $28.72 2021
Ascendis Pharma Endocrinology INC $24.38 2023
Embecta Corp. $24.13 2023 Bd Nano 2nd Gen Pen Needle
Sequel Med Tech, LLC $21.25 2025 Twiist
Tandem Diabetes Care, INC. $17.39 2024 T:Slim X2 Insulin Pump With Control-Iq
Mannkind Corporation $16.91 2024
Ultragenyx Pharmaceutical INC. $16.53 2024 Crysvita
Ucb, INC. $15.17 2023
Jazz Pharmaceuticals INC. $14.24 2021
Zealand Pharma US, INC. $13.22 2021
Adlon Therapeutics L.P. $11.89 2021
Esperion Therapeutics, INC. $11.69 2021
Amneal Pharmaceuticals LLC $11.17 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Traci R Evans

$8,179.32

in general payments reported 2019-2025

Years
2021-2025
Top company
Lilly USA, LLC
Context
The $1,165 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).

https://glasscript.com/doctor/10886261/traci-r-evans

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.